A third scientist employed by GlaxoSmithKline pleaded guilty to stealing trade secrets – including the science behind COVID-19 treatments – to boost a competing, state-funded Chinese pharmaceutical company. Lucy Xi, along with three co-defendants, established the Chinese pharmaceutical company Renopharma with funding from the Chinese Communist Party to supposedly research and develop anti-cancer drugs. The team, however, used the company as a vessel to steal information from GlaxoSmithKline (GSK) in the United States. Xi and her colleagues worked at a GSK facility in Upper Merion, Pennsylvania. In January 2015, she sent co-conspirator Yan Mei a GSK document containing “confidential and
